Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani, Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients, in: Blood, «BLOOD», 2012, 120, pp. 4951 - 4951 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [atti di convegno-abstract]
Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carla Filì; Costanza Bosi; Marilisa Quaranta; Stefania Paolini; Anna Maria Billi; Marco Gobbi; Michele Baccarani; Domenico Russo; Giovanni Martinelli; Lucia Manzoli; Lucio Cocco, Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients, in: Blood, «BLOOD», 2012, 120, pp. 1289 - 1289 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [atti di convegno-abstract]
Matilde Y. Follo; Sara Mongiorgi; Carlo Finelli; Manuela Piazzi; Irene Faenza; Giulia Ramazzotti; Patrizia Santi; James A. McCubrey; Alberto M. Martelli; Lucio Cocco, Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics, «CURRENT PHARMACEUTICAL DESIGN», 2012, 18, pp. 1751 - 1754 [articolo]
Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Carla Filì; Chiara Colombi; Michele Baccarani; Giovanni Martinelli; Domenico Russo; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco, Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment, in: BLOOD, 2010, 116, pp. 108 - 108 (atti di: 52th ASH ANNUAL MEETING AND EXPOSITION, ORLANDO, FL, 4-7 DECEMBER 2010) [Contributo in Atti di convegno]
Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L., Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia., «JOURNAL OF CLINICAL ONCOLOGY», 2009, 27, pp. 782 - 790 [articolo]
Follo MY; Finelli C; Bosi C; Martinelli G; Mongiorgi S; Baccarani M; Manzoli L; Blalock WL; Martelli AM; Cocco L, PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes, «LEUKEMIA», 2008, 22, pp. 198 - 200 [articolo]
